Last edition
News about "Tecentriq Hybreza FDA approval"
US FDA Approves Atezolizumab for Stage 3 dMMR Colon Cancer
The US FDA has approved atezolizumab with chemotherapy for stage 3 dMMR colon cancer in patients aged 12 years and older who weigh at least 40 kg.
Tecentriq Hybreza FDA Approval | 12/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members